Purdue Pharma will pay multibillion-dollar opioid settlement by selling more opioids

Brasil Notícia Notícia

Purdue Pharma will pay multibillion-dollar opioid settlement by selling more opioids
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 97%

Two dozen states have rejected the deal.

The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin.

Massachusetts is among the several states that have pledged to continue pushing back in court against the company and especially members of the Sackler family, which owns Purdue. On Tuesday, North Carolina became the latest state to sue the Sacklers. While OxyContin and other prescription drugs like it have what are widely accepted as legitimate medical purposes — namely, relieving severe pain — activists and others are troubled by the prospect of the continued sale of Purdue’s opioids in the U.S. and overseas.

“It’s disgraceful,” said Ed Bisch, of Pennsauken, New Jersey, who was among the first parents to take on Purdue. His son died of an OxyContin overdose at 18 in 2001. “If they keep on selling OxyContin, there’s going to be more and more accidental addicts.” Those payments continue to this day. By last year, the master settlement with 46 states had resulted in a payout of $126 billion, with continuing payments of $9 billion a year.

“The medicine itself is not inherently evil,” Hampton said. Besides, he said, “This money is going to have to come from somewhere or there’s no money at all.”

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

MarketWatch /  🏆 3. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Purdue Pharma files for bankruptcy as part of settlementPurdue Pharma files for bankruptcy as part of settlementPurdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids.
Consulte Mais informação »

OxyContin maker Purdue Pharma files for bankruptcy protectionOxyContin maker Purdue Pharma files for bankruptcy protectionPurdue Pharma, the company behind OxyContin, files for bankruptcy protection amid more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic. More here:
Consulte Mais informação »

OxyContin Maker Purdue Pharma Files For Bankruptcy Over Opioid SettlementOxyContin Maker Purdue Pharma Files For Bankruptcy Over Opioid SettlementThe Chapter 11 filing, approved on Sunday, comes after a tentative deal struck with dozens of states to settle thousands of lawsuits over Purdue's alleged role in the opioid crisis.
Consulte Mais informação »

Purdue Pharma files for bankruptcy as part of settlementPurdue Pharma files for bankruptcy as part of settlementPurdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy in White Plains, New York, days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids. "This settlement framework avoids
Consulte Mais informação »

Purdue Pharma files for bankruptcy as part of settlementPurdue Pharma files for bankruptcy as part of settlementThe company that makes the painkiller Oxycontin, Purdue Pharma, has filed for bankruptcy protection as part of an effort to settle thousands of lawsuits connected to the opioid crisis. NBC’s Kate Snow joins Stephanie Ruhle to explain what this means for all of those lawsuits.
Consulte Mais informação »

Purdue Pharma files for bankruptcy as part of opioid crisis lawsuitsPurdue Pharma files for bankruptcy as part of opioid crisis lawsuitsPurdue Pharma files for bankruptcy as part of opioid crisis lawsuits as many state attorneys vow to keep fighting the makers of OxyContin.
Consulte Mais informação »



Render Time: 2025-04-01 13:27:49